Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
30
pubmed:dateCreated
2004-7-29
pubmed:abstractText
Despite its pharmacological relevance, the mechanism of the development of tolerance to the action of benzodiazepines is essentially unknown. The acute sedative action of diazepam is mediated via alpha1-GABA(A) receptors. Therefore, we tested whether chronic activation of these receptors by diazepam is sufficient to induce tolerance to its sedative action. Knock-in mice, in which thealpha1-,alpha2-,alpha3-, oralpha(5)-GABA(A) receptors had been rendered insensitive to diazepam by histidine-arginine point mutation, were chronically treated with diazepam (8 d; 15 mg x kg(-1) x d(-1)) and tested for motor activity. Wild-type, alpha2(H101R), and alpha3(H126R) mice showed a robust diminution of the motor-depressant drug action. In contrast, alpha5(H105R) mice failed to display any sedative tolerance. alpha1(H101R) mice showed no alteration of motor activity with chronic diazepam treatment. Autoradiography with [3H]flumazenil revealed no change in benzodiazepine binding sites. However, a decrease in alpha5-subunit radioligand binding was detected selectively in the dentate gyrus with specific ligands. This alteration was observed only in diazepam-tolerant animals, indicating that the manifestation of tolerance to the sedative action of diazepam is associated with a downregulation of alpha5-GABA(A) receptors in the dentate gyrus. Thus, the chronic activation of alpha(5)-GABA(A) receptors is crucial for the normal development of sedative tolerance to diazepam, which manifests itself in conjunction with alpha1-GABA(A) receptors.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
28
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
6785-90
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:15282283-Alkynes, pubmed-meshheading:15282283-Allosteric Regulation, pubmed-meshheading:15282283-Amino Acid Substitution, pubmed-meshheading:15282283-Animals, pubmed-meshheading:15282283-Benzodiazepines, pubmed-meshheading:15282283-Binding Sites, pubmed-meshheading:15282283-Brain Chemistry, pubmed-meshheading:15282283-Corpus Striatum, pubmed-meshheading:15282283-Crosses, Genetic, pubmed-meshheading:15282283-Dentate Gyrus, pubmed-meshheading:15282283-Diazepam, pubmed-meshheading:15282283-Down-Regulation, pubmed-meshheading:15282283-Drug Tolerance, pubmed-meshheading:15282283-Female, pubmed-meshheading:15282283-Hippocampus, pubmed-meshheading:15282283-Hypnotics and Sedatives, pubmed-meshheading:15282283-Imidazoles, pubmed-meshheading:15282283-Mice, pubmed-meshheading:15282283-Motor Activity, pubmed-meshheading:15282283-Motor Cortex, pubmed-meshheading:15282283-Nucleus Accumbens, pubmed-meshheading:15282283-Point Mutation, pubmed-meshheading:15282283-Protein Subunits, pubmed-meshheading:15282283-Radioligand Assay, pubmed-meshheading:15282283-Receptors, GABA-A, pubmed-meshheading:15282283-Recombinant Fusion Proteins
pubmed:year
2004
pubmed:articleTitle
Requirement of alpha5-GABAA receptors for the development of tolerance to the sedative action of diazepam in mice.
pubmed:affiliation
Institute of Pharmacology and Toxicology, University of Zürich, 8057 Zürich, Switzerland.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't